Abstract: An encoding method, a decoding method, and an apparatus. A symbol quantity S is determined based on an encoding bit quantity L and an energy level quantity B, where S is S1 or S2, S1=L/B, and S2=L/2B. K information sub-channels are determined from an encoding sequence based on the symbol quantity S, the energy level quantity B, and a reliability sequence. K information bits are encoded and a bit sequence is output based on the K information sub-channels, where the K information sub-channels are selected from candidate sub-channels based on an order of reliability of the candidate sub-channels. The candidate sub-channels are S1 sub-channels or 2×S2 sub-channels in a sub-sequence whose energy level is i in the encoding sequence.

Abstract: This application discloses a NB-IoT-based communication method and an apparatus, to evolve a NB-IoT communication technology into an NTN. The method is as follows: A terminal device generates an uplink signal, including a superframe which includes a synchronization sequence located in first duration of the superframe and a data frame located in second duration which is after the first duration, the synchronization sequence successively includes a first sequence repeated Ni times and a second sequence repeated N2 times, the second sequence is obtained by multiplying the first sequence by ?1, a part of consecutive sequences of the synchronization sequence are used as a first synchronization reference sequence that is obtained based on the second sequence repeated N2 times and one or more first sequences that are sorted from back to front in the first sequence repeated N1 times. The terminal device sends the uplink signal to a network device.

Abstract: The present disclosure provides use of Clostridium ghonii combined with a tumor angiogenesis inhibitor in preparing a pharmaceutical product for treating a tumor. The present disclosure further provides a drug for treating a tumor, where the drug includes active ingredients of Clostridium ghonii and a tumor angiogenesis inhibitor.

Abstract: Disclosed are a shield tunnel segment structure and a construction method thereof. The shield tunnel segment structure includes segment blocks sequentially spliced in a circumferential direction. Each segment block forms a closed annular segment structure, and outer diameters of adjacent annular segment structures gradually increase in an axial direction. At least two adjacent segment blocks of the same annular segment structure form an annular inner groove, and at least one segment block of the adjacent annular segment structures is provided with an inner bump which matches the annular inner groove. At least two adjacent segment blocks of the same annular segment structure form an annular outer groove, and at least one segment block of the adjacent annular segment structures is provided with an outer bump which matches the annular outer groove. The annular outer grooves and the annular inner grooves are staggered in the circumferential direction.

Abstract: The present disclosure is directed to compositions and methods of treating arthritogenic alphavirus infection. Compositions include a fusion protein comprising an Fc region, a first Mxra8 region, and a second Mxra8 region, wherein the fusion protein reduces inflammation and infection by an arthritogenic alphavirus. Methods include administering the fusion protein to a mammalian or non-mammalian subject to reduce or inhibit alphavirus infection.

Abstract: Disclosed is the use of a composition containing cilostazol or a pharmaceutically acceptable salt thereof and edaravone in the preparation of a drug for treating cerebrovascular diseases, especially ischemic cerebrovascular diseases. The experiment result shows that the tail vein administration of 1-15 mg/kg of cilostazol or 1.67-8.33 mg/kg of edaravone on rats with a focal cerebral ischemia-reperfusion injury can significantly ameliorate neurological defects in rats with an MCAO and reduce a cerebral infarction area; and performing compound combination within the dosage range (the mass ratio of cilostazol:edaravone is 1:5 to 5:1) can be synergistic. The tail vein administration of 3.33-16.67 mg/kg of cilostazol or 3.33-16.67 mg/kg of edaravone on mice with a focal cerebral ischemia-reperfusion injury can significantly ameliorate neurological defects in mice with an MCAO and reduce a cerebral infarction area.

Abstract: A resource mapping method and apparatus are described that reduce resource mapping complexity. The method includes an access network device obtaining resource mapping information of at least one terminal, and sending the resource mapping information to the at least one terminal respectively. The resource mapping information indicates a resource element RE to which each of the at least one terminal performs mapping in each RMB in a first resource mapping block RMB set. An RE to which a first terminal performs mapping in each RMB in the first RMB set is determined based on a first interleaved sequence, and the first interleaved sequence is determined based on a base sequence. The first terminal is any one of the at least one terminal, and the first RMB set includes at least one RMB.

Abstract: The present disclosure relates to use of a Clostridium ghonii spore combined with pembrolizumab in cancer treatment. It is found for the first time that the Clostridium ghonii spore combined with pembrolizumab can significantly improve a curative effect of colon cancer and reduce a dose of the pembrolizumab, and thus is efficient and low-toxic. Oncolysis by Clostridium ghonii can affect immunogenicity of a tumor microenvironment (TME) by various ways, converts an immunosuppressive state of the TME into an immune-activated state, adjusts the immunosuppressive TME, and breaks an immune tolerance. An optimal combination of the Clostridium ghonii spore and the pembrolizumab thoroughly removes about 20% of mouse tumor tissues. A benefit range of patients with tumors treated by a PD-1 antibody is expanded. The combination even has an obvious curative effect on patients failed the treatment by the PD-1 antibody.

Abstract: A terminal device obtains first slice selection assistance information, where the first slice selection assistance information is obtained by encrypting second slice selection assistance information, and the second slice selection assistance information is selection assistance information of a slice to which the terminal device is allowed to access. The terminal device sends a registration request message to an access network device, where the registration request message includes the first slice selection assistance information.

Abstract: A network function service invocation method includes sending, by a first network function network element, a first request message to an authorization network element, wherein the first request message is used to request permission to invoke a first network function service provided by a second network function network element, performing, by the authorization network element, identity authentication on the first network function network element, generating, by the authorization network element, a token when determining that the identity authentication succeeds, wherein the token is used to indicate that the first network function network element has the permission to invoke the first network function service of the second network function network element, and sending, by the authorization network element, a token to the first network function network element.

Abstract: A live detection system, a thermal infrared (IR) imager and a method for power grid equipment are provided. The system includes an environmental parameter module for acquiring environmental temperature, humidity and wind speed data; a ranging module for measuring a linear distance to the power grid equipment; an equipment type recognition module for acquiring an image of the power grid equipment, and recognizing a type of the power grid equipment; an equipment material determination module for determining a material type of the power grid equipment; an emissivity setting module for setting an emissivity; an temperature measurement module for obtaining a temperature of the power grid equipment by focusing on positions of the power grid equipment which need temperature measurement; and a report generation module for selecting a corresponding diagnostic model, displaying a temperature measurement position and a temperature value, drawing a conclusion, and generating a report.

Abstract: Disclosed are a device and method for detecting defects of a high-voltage cable cross-bonded grounding system. The method comprises: selecting a protective grounding box of a cross-bonded grounding system, respectively connecting a signal excitation coupler to A-phase, B-phase and C-phase coaxial cables of the protective grounding box, selecting a stable signal with a frequency different from a power frequency or a field interference frequency, and testing effective current values and phases responded by the A-phase, B-phase and C-phase coaxial cables when the stable signal with the frequency F1 is injected into the A-phase, B-phase and C-phase coaxial cables of the protective grounding box in a coupled manner; and obtaining resistances and inductances of branch circuits of the cable cross-bonded grounding system by calculation according to measurement data, and determining if the cable cross-bonded grounding system has a connection defect.

Abstract: Disclosed is a plane grating calibration system, comprising an optical subsystem, a frame, first vibration isolator, a vacuum chuck, a workpiece stage, second vibration isolator, a base platform and a controller; the optical subsystem is mounted on the frame, and the frame is isolated from vibration by the first vibration isolator; the vacuum chuck is rotatably mounted on the workpiece stage, the workpiece stage is positioned on the base platform, and the base platform is isolated from vibration by the second vibration isolator. A displacement interferometer is integrated into the optical subsystem, and the entire optical subsystem adopts a method of sharing a light source, thereby avoiding the problems of low wavelength precision and poor coherence of separate light sources.

Abstract: An information transmission method and an apparatus. The information transmission method includes: a receive end sends first indication information, where the first indication information indicates a target receiving mode of the receive end, and the target receiving mode is one of a plurality of receiving modes. The receive end receives service information based on the target receiving mode. The receive end performs decoding processing on the service information based on the target receiving mode. In this way, power consumption can be further reduced, and information transmission of a plurality of service types can be supported, thereby improving information transmission flexibility and user experience.

Abstract: A responding station (STA) for adaptive ranging may comprise a transceiver configured to receive, from an initiating STA, a signal comprising one or more of a frame or a data packet, and a processing device. The processing device may be configured to: identify, at the responding STA, one or more of the frame or the data packet; identify, at the responding STA, one or more physical layer measurements based on the one or more of the frame or the data packet; identify, at the responding STA, one or more application layer requests comprising a ranging accuracy level; and determine, at the responding STA, one or more ranging parameters for a ranging operation based on the one or more physical layer measurements and the ranging accuracy level.

Abstract: A processor may automatically generate one or more transcripts based on a media context. The processor may append at least one of the one or more transcripts to the media. The processor may modify the at least one of the one or more transcripts based on an adjustment to a weight factor.

Abstract: The present invention belongs to the pharmaceutical field, and relates to an application of a cilostazol and d-borneol composition in preparing a drug for treating cerebrovascular disease, in particular ischemic cerebrovascular disease. The present invention specifically relates to a composition containing cilostazol or a pharmaceutically acceptable salt thereof and d-borneol, and an application of the composition in preparing a drug for treating cerebrovascular disease, in particular ischemic cerebrovascular disease.

Abstract: A first machine learning model is deployed in a first communication apparatus, and a second machine learning model is deployed in a second communication apparatus. First information is obtained that carries indication information of both a first transmission resource and a second transmission resource, wherein the first transmission resource is for the first communication apparatus to transmit a first output of the first machine learning model to the second communication apparatus, and wherein the second transmission resource is for the first communication apparatus to receive first feedback data that is from the second communication apparatus. The first feedback data includes a first gradient, wherein the first gradient is for updating the first machine learning model. The first communication apparatus transmits the first output to the second communication apparatus on the first transmission resource.

Abstract: Disclosed is a method for preparing a three-dimensional porous nano composite cooling film in large scale. The cooling film is prepared from 0.1-0.5 parts of cellulose acetate, 1-5 parts of water, 20-100 parts of acetone, an additive, and 10-20 parts of nano microspheres through a cooperative formulation of cellulose acetate, nano microsphere materials and the additive. The composite cooling film is obtained by self-deposition of cellulose acetate and nano microspheres, and liquid volatilization during film forming process leads to formation of the three-dimensional porous structure. The film has an effect of enhancing radiation of infrared heat into space, which could significantly reduce a temperature of a substrate surface and achieve rapid and strong cooling. The film could achieve effective cooling without external power and other active cooling equipment, with or without sunlight.